{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:12:01Z","timestamp":1790871121686,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004578","name":"Ministry of Industry and Trade","doi-asserted-by":"publisher","award":["14411.2049999.19.069"],"award-info":[{"award-number":["14411.2049999.19.069"]}],"id":[{"id":"10.13039\/501100004578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.antiviral.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T16:16:51Z","timestamp":1494692211000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Study of rubella candidate vaccine based on a structurally modified plant virus"],"prefix":"10.1016","volume":"144","author":[{"given":"Ekaterina A.","family":"Trifonova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Zenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai A.","family":"Nikitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Yurkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-8285","authenticated-orcid":false,"given":"Ekaterina M.","family":"Ryabchevskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor V.","family":"Putlyaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5872-3928","authenticated-orcid":false,"given":"Ekaterina K.","family":"Donchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Kondakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey N.","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Atabekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Karpova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.antiviral.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2567.2007.02753.x","article-title":"Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus","volume":"124","author":"Acosta-Ram\u00edrez","year":"2008","journal-title":"Immunology"},{"issue":"Pt 2","key":"10.1016\/j.antiviral.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/vir.0.024356-0","article-title":"Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles","volume":"92","author":"Atabekov","year":"2011","journal-title":"J.\u00a0General Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3103\/S0096392515040045","article-title":"New type platforms for in\u00a0vitro vaccine assembly","volume":"70","author":"Atabekov","year":"2015","journal-title":"Mosc. Univ. Biol. Sci. Bull."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2567.2001.01213.x","article-title":"Tumours can act as adjuvants for humoral immunity","volume":"102","author":"Brown","year":"2001","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1440-1711.2005.01339.x","article-title":"Use of viral vectors for vaccine production in plants","volume":"83","author":"Ca\u00f1izares","year":"2005","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0042-6822(92)90572-7","article-title":"Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus","volume":"189","author":"Chaye","year":"1992","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00919265","article-title":"Human T- and B-cell epitopes of E1 glycoprotein of rubella virus","volume":"13","author":"Chaye","year":"1993","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.antiviral.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2009.03.002","article-title":"Immunogenicity of zona pellucida glycoprotein-3 and spermatozoa YLP(12) peptides presented on Johnson grass mosaic virus-like particles","volume":"27","author":"Choundry","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/vim.2000.13.83","article-title":"Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells","volume":"13","author":"Corboba","year":"2000","journal-title":"Viral Immunol."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-1702(95)00037-Q","article-title":"Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model","volume":"37","author":"Cusi","year":"1995","journal-title":"Virus Res."},{"issue":"27\u201328","key":"10.1016\/j.antiviral.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A\u00a0good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J.\u00a0Appl. Toxicol. JAT"},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/07391102.2013.788983","article-title":"\u03b2-structure of the coat protein subunits in spherical particles generated by tobacco mosaic virus thermal denaturation","volume":"32","author":"Dobrov","year":"2014","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"issue":"7433","key":"10.1016\/j.antiviral.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature11741","article-title":"Functional and evolutionary insight from the crystal structure of rubella virus protein E1","volume":"493","author":"DuBois","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib16","first-page":"264","article-title":"Economic analyses of rubella and rubella vaccines: a global review","volume":"80","author":"Hinman","year":"2002","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2017.05.006_bib17","series-title":"Current Issues in Molecular Virology-viral Genetics and Biotechnological Applications","first-page":"239","article-title":"Vaccines and antiviral agents","author":"Hongxuan","year":"2013"},{"key":"10.1016\/j.antiviral.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(94)00477-3","article-title":"The immobilized movement proteins of two tobamoviruses form stable ribonucleoprotein complexes with full-length viral genomic RNA","volume":"346","author":"Ivanov","year":"1994","journal-title":"FEBS Lett."},{"issue":"Pt 2","key":"10.1016\/j.antiviral.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1099\/vir.0.036293-0","article-title":"Immunogenic compositions assembled from tobacco mosaic virus-generated spherical particle platforms and foreign antigens","volume":"93","author":"Karpova","year":"2012","journal-title":"J.\u00a0General virol."},{"issue":"14","key":"10.1016\/j.antiviral.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.1073\/pnas.96.14.7774","article-title":"Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope","volume":"96","author":"Koo","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.1302030","article-title":"Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infection","volume":"192","author":"Lebel","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/vim.2014.0021","article-title":"R237 and H238 are key amino acids in the rubella virus E1 neutralization epitope","volume":"27","author":"Li","year":"2014","journal-title":"Viral Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcp.21423","article-title":"Viral vectors for production of recombinant proteins in plants","volume":"216","author":"Lico","year":"2008","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.21.1.117-121.1985","article-title":"Subclass distribution of rubella virus-specific immunoglobulin G","volume":"21","author":"Linde","year":"1985","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1743-422X-9-75","article-title":"Immune response to a potyvirus with exposed amino groups available for chemical conjugation","volume":"9","author":"Manuel-Cabrera","year":"2012","journal-title":"Virol. J."},{"issue":"7","key":"10.1016\/j.antiviral.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.nano.2013.02.009","article-title":"Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge","volume":"9","author":"Mathieu","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14760584.7.1.33","article-title":"Genetically engineered Tobacco mosaic virus as nanoparticle vaccines","volume":"7","author":"McCormick","year":"2008","journal-title":"Expert Rev. Vaccines"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1096-9071(199704)51:4<280::AID-JMV4>3.0.CO;2-1","article-title":"The role of rubella-immunoblot and rubella-peptide-EIA for the diagnosis of the congenital rubella syndrome during the prenatal and newborn periods","volume":"51","author":"Meitsch","year":"1997","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-2836(89)90391-4","article-title":"Visualization of protein-nucleic acid interactions in a virus. Refined structure of intact tobacco mosaic virus at 2.9\u2009\u00c5 resolution by X-ray fiber diffraction","volume":"208","author":"Namba","year":"1989","journal-title":"J.\u00a0Mol. Biol."},{"issue":"11","key":"10.1016\/j.antiviral.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1134\/S0965545X11110083","article-title":"Use of a polycation spacer for noncovalent immobilization of albumin on thermally modified virus particles","volume":"53","author":"Nikitin","year":"2011","journal-title":"Polym. Sci. Ser. A"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib31","first-page":"808","article-title":"Examination of biologically active nanocomplexes by nanoparticle tracking analysis","volume":"19","author":"Nikitin","year":"2013","journal-title":"Microsc. Microanal. Off. J. Microsc. Soc. Am. Microbeam Anal. Soc. Microsc. Soc. Can."},{"issue":"16","key":"10.1016\/j.antiviral.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/09205063.2014.946877","article-title":"Proteins immobilization on the surface of modified plant viral particles coated with hydrophobic polycations","volume":"25","author":"Nikitin","year":"2014","journal-title":"J.\u00a0Biomater. Sci. Polym. Ed."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3103\/S0096392516030081","article-title":"Biosafety of plant viruses for human and animals","volume":"71","author":"Nikitin","year":"2016","journal-title":"Mosc. Univ. Biol. Sci. Bull."},{"issue":"12","key":"10.1016\/j.antiviral.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.humimm.2004.07.001","article-title":"The contribution of HLA class I antigens in immune status following two doses of rubella vaccination","volume":"65","author":"Ovsyannikova","year":"2004","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.antiviral.2017.05.006_bib35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.vaccine.2016.01.010","article-title":"The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines","volume":"34","author":"Petrova","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.05.006_bib36","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.2174\/13816128113199990337","article-title":"Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors","volume":"19","author":"Petukhova","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2017.05.006_bib37","series-title":"Vaccines","author":"Plotkin","year":"2013"},{"key":"10.1016\/j.antiviral.2017.05.006_bib38","series-title":"The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models","first-page":"171","article-title":"Clinical chemistry of the laboratory mouse","volume":"vol. III","author":"Quimby","year":"2007"},{"issue":"2","key":"10.1016\/j.antiviral.2017.05.006_bib39","doi-asserted-by":"crossref","first-page":"e31925","DOI":"10.1371\/journal.pone.0031925","article-title":"Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites","volume":"7","author":"Rioux","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2017.05.006_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-3155-12-19","article-title":"PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine","volume":"12","author":"Rioux","year":"2014","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.antiviral.2017.05.006_bib41","doi-asserted-by":"crossref","first-page":"e22215","DOI":"10.5812\/hepatmon.22215","article-title":"Immunogenicity of multi-epitope DNA and peptide vaccine candidates based on core, E2, NS3 and NS5B HCV epitopes in BALB\/c mice","volume":"14","author":"Pishraft Sabet","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.antiviral.2017.05.006_bib42","series-title":"Molecular Cloning: a Laboratory Manual","author":"Sambrook","year":"1989"},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/00222615-21-4-283","article-title":"Subclass distribution of IgG and IgA responses to rubella virus in man","volume":"21","author":"Stokes","year":"1986","journal-title":"J.\u00a0Med. Microbiol."},{"issue":"3","key":"10.1016\/j.antiviral.2017.05.006_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1017\/S0950268800067182","article-title":"Specific IgG subclass antibody in rubella virus infections","volume":"100","author":"Thomas","year":"1988","journal-title":"Epidemiol. Infect."},{"issue":"6","key":"10.1016\/j.antiviral.2017.05.006_bib45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2009.0068","article-title":"Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity","volume":"22","author":"Tosh","year":"2009","journal-title":"Viral Immunol."},{"issue":"8","key":"10.1016\/j.antiviral.2017.05.006_bib46","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/07391102.2013.816868","article-title":"Complexes assembled from TMV-derived spherical particles and entire virions of heterogeneous nature","volume":"32","author":"Trifonova","year":"2014","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.antiviral.2017.05.006_bib47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3103\/S0096392515040094","article-title":"Obtaining and characterization of spherical particles\u2014new biogenic platforms","volume":"70","author":"Trifonova","year":"2015","journal-title":"Mosc. Univ. Biol. Sci. Bull."},{"key":"10.1016\/j.antiviral.2017.05.006_bib48","doi-asserted-by":"crossref","first-page":"20151101","DOI":"10.1098\/rsif.2015.1101","article-title":"Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination","volume":"13","author":"Wesolowski","year":"2015","journal-title":"J.\u00a0R. Soc. Interface"},{"key":"10.1016\/j.antiviral.2017.05.006_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.67.2.961-968.1993","article-title":"An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain","volume":"67","author":"Wolinsky","year":"1993","journal-title":"J.\u00a0Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217300797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T16:48:15Z","timestamp":1602089295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217300797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":49,"alternative-id":["S0166354217300797"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of rubella candidate vaccine based on a structurally modified plant virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}